Campbell & Co. Investment Adviser »

Crispr Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.9M 108k 54.54
2024-09-30 $861k 18k 46.98
2024-03-31 $608k 8.9k 68.16

More positions owned by Campbell & Co. Investment Adviser

Hilton Worldwide Holdings Common Stock (HLT)
Petroleo Brasileiro SA - Petro Adr (PBR)
Darling Ingredients Common Stock (DAR)
Hartford Insurance Group Inc/T Common Stock (HIG)
Atmos Energy Corp Common Stock (ATO)
Marriott International Common Stock (MAR)
LyondellBasell Industries NV Common Stock (LYB)
Westlake Corp Common Stock (WLK)
Mettler-Toledo International I Common Stock (MTD)
Labcorp Holdings Common Stock (LH)
Loews Corp Common Stock (L)
US Bancorp Common Stock (USB)
Primerica Common Stock (PRI)
Mastercard Common Stock (MA)
Wells Fargo & Co Common Stock (WFC)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
GSK
Geode Capital Management
Sr One Capital Management
Two Sigma Investments
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
EcoR1 Capital
UBS Group
Capital Research and Management Company - Division 3

View all funds holding Crispr Therapeutics